1-(2-(2,6-dioxopiperazin-1-yl)propyl)piperazine-2,6-dione

ID: ALA4087430

PubChem CID: 22368087

Max Phase: Preclinical

Molecular Formula: C11H16N4O4

Molecular Weight: 268.27

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(CN1C(=O)CNCC1=O)N1C(=O)CNCC1=O

Standard InChI:  InChI=1S/C11H16N4O4/c1-7(15-10(18)4-13-5-11(15)19)6-14-8(16)2-12-3-9(14)17/h7,12-13H,2-6H2,1H3

Standard InChI Key:  OHTAHPUATLWIOP-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 20  0  0  0  0  0  0  0  0999 V2000
    2.7364   -2.6208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9192   -2.6167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5093   -3.3184    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9120   -4.0288    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7292   -4.0329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1437   -3.3267    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1468   -1.9142    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1335   -4.7431    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9608   -3.3297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3668   -4.0389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1840   -4.0418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5879   -4.7517    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4015   -4.7567    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8165   -4.0523    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4117   -3.3413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5920   -3.3347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1749   -5.4569    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.1861   -2.6254    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.3720   -2.6234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  1  7  2  0
  5  8  2  0
  6  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  1  0
 12 17  2  0
 16 18  2  0
  9 19  1  0
M  END

Associated Targets(Human)

NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 268.27Molecular Weight (Monoisotopic): 268.1172AlogP: -2.71#Rotatable Bonds: 3
Polar Surface Area: 98.82Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.59CX LogP: -2.97CX LogD: -2.97
Aromatic Rings: Heavy Atoms: 19QED Weighted: 0.54Np Likeness Score: -0.43

References

1. Kumar A, Banerjee S, Roy P, Sondhi SM, Sharma A..  (2017)  Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity.,  27  (3): [PMID:28011220] [10.1016/j.bmcl.2016.12.031]

Source